Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (RGO)

Market Closed
11 Apr, 20:00
484. 60
-34.8
-6.7%
- Market Cap
24.52 P/E Ratio
0% Div Yield
0 Volume
42.79 Eps
519.4
Previous Close
Day Range
484.6 484.6
Year Range
482.1 1,086.5
Earnings results expected in 17 days
Want to track RGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
30 Apr 2025 (17 Days)
-
Cons. EPS
-
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
31 Jan 2025
11.38
Cons. EPS
12.07
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
31 Oct 2024
11.69
Cons. EPS
12.46
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
1 Aug 2024
10.61
Cons. EPS
11.56
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 May 2024
10.09
Cons. EPS
9.55
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 Feb 2024
10.73
Cons. EPS
11.86
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
2 Nov 2023
10.72
Cons. EPS
11.59
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Nov 2016
2.71
Cons. EPS
3.13
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
4 Aug 2016
2.65
Cons. EPS
2.82
EPS
Regeneron Pharmaceuticals, Inc. logo
REGN Regeneron Pharmaceuticals, Inc.
5 May 2016
2.58
Cons. EPS
2.57
EPS